204 related articles for article (PubMed ID: 22615748)
1. Absence of XMRV and closely related viruses in primary prostate cancer tissues used to derive the XMRV-infected cell line 22Rv1.
Das Gupta J; Luk KC; Tang N; Gaughan C; Klein EA; Kandel ES; Hackett J; Silverman RH
PLoS One; 2012; 7(5):e36072. PubMed ID: 22615748
[TBL] [Abstract][Full Text] [Related]
2. In-depth investigation of archival and prospectively collected samples reveals no evidence for XMRV infection in prostate cancer.
Lee D; Das Gupta J; Gaughan C; Steffen I; Tang N; Luk KC; Qiu X; Urisman A; Fischer N; Molinaro R; Broz M; Schochetman G; Klein EA; Ganem D; Derisi JL; Simmons G; Hackett J; Silverman RH; Chiu CY
PLoS One; 2012; 7(9):e44954. PubMed ID: 23028701
[TBL] [Abstract][Full Text] [Related]
3. Recombinant origin of the retrovirus XMRV.
Paprotka T; Delviks-Frankenberry KA; Cingöz O; Martinez A; Kung HJ; Tepper CG; Hu WS; Fivash MJ; Coffin JM; Pathak VK
Science; 2011 Jul; 333(6038):97-101. PubMed ID: 21628392
[TBL] [Abstract][Full Text] [Related]
4. Disease-associated XMRV sequences are consistent with laboratory contamination.
Hué S; Gray ER; Gall A; Katzourakis A; Tan CP; Houldcroft CJ; McLaren S; Pillay D; Futreal A; Garson JA; Pybus OG; Kellam P; Towers GJ
Retrovirology; 2010 Dec; 7(1):111. PubMed ID: 21171979
[TBL] [Abstract][Full Text] [Related]
5. Xenotropic murine leukemia virus-related virus (XMRV) in prostate cancer cells likely represents a laboratory artifact.
Yang J; Battacharya P; Singhal R; Kandel ES
Oncotarget; 2011 May; 2(5):358-62. PubMed ID: 21642749
[TBL] [Abstract][Full Text] [Related]
6. No association between XMRV or related gammaretroviruses in Australian prostate cancer patients.
Rezaei SD; Hearps AC; Mills J; Pedersen J; Tachedjian G
Virol J; 2013 Jan; 10():20. PubMed ID: 23305518
[TBL] [Abstract][Full Text] [Related]
7. XMRV: a new virus in prostate cancer?
Aloia AL; Sfanos KS; Isaacs WB; Zheng Q; Maldarelli F; De Marzo AM; Rein A
Cancer Res; 2010 Dec; 70(24):10028-33. PubMed ID: 20966126
[TBL] [Abstract][Full Text] [Related]
8. XMRV induces cell migration, cytokine expression and tumor angiogenesis: are 22Rv1 cells a suitable prostate cancer model?
Stieler K; Schumacher U; Horst AK; Fischer N
PLoS One; 2012; 7(7):e42321. PubMed ID: 22848758
[TBL] [Abstract][Full Text] [Related]
9. XMRV and prostate cancer--a 'final' perspective.
Sfanos KS; Aloia AL; De Marzo AM; Rein A
Nat Rev Urol; 2012 Jan; 9(2):111-8. PubMed ID: 22231291
[TBL] [Abstract][Full Text] [Related]
10. No association of xenotropic murine leukemia virus-related viruses with prostate cancer.
Switzer WM; Jia H; Zheng H; Tang S; Heneine W
PLoS One; 2011 May; 6(5):e19065. PubMed ID: 21573232
[TBL] [Abstract][Full Text] [Related]
11. No evidence of XMRV in prostate cancer cohorts in the Midwestern United States.
Sakuma T; Hué S; Squillace KA; Tonne JM; Blackburn PR; Ohmine S; Thatava T; Towers GJ; Ikeda Y
Retrovirology; 2011 Mar; 8():23. PubMed ID: 21447170
[TBL] [Abstract][Full Text] [Related]
12. No detection of XMRV in blood samples and tissue sections from prostate cancer patients in Northern Europe.
Stieler K; Schindler S; Schlomm T; Hohn O; Bannert N; Simon R; Minner S; Schindler M; Fischer N
PLoS One; 2011; 6(10):e25592. PubMed ID: 22022417
[TBL] [Abstract][Full Text] [Related]
13. Mouse DNA contamination in human tissue tested for XMRV.
Robinson MJ; Erlwein OW; Kaye S; Weber J; Cingoz O; Patel A; Walker MM; Kim WJ; Uiprasertkul M; Coffin JM; McClure MO
Retrovirology; 2010 Dec; 7():108. PubMed ID: 21171966
[TBL] [Abstract][Full Text] [Related]
14. Xenotropic MLV envelope proteins induce tumor cells to secrete factors that promote the formation of immature blood vessels.
Murgai M; Thomas J; Cherepanova O; Delviks-Frankenberry K; Deeble P; Pathak VK; Rekosh D; Owens G
Retrovirology; 2013 Mar; 10():34. PubMed ID: 23537062
[TBL] [Abstract][Full Text] [Related]
15. Contamination of human DNA samples with mouse DNA can lead to false detection of XMRV-like sequences.
Oakes B; Tai AK; Cingöz O; Henefield MH; Levine S; Coffin JM; Huber BT
Retrovirology; 2010 Dec; 7():109. PubMed ID: 21171973
[TBL] [Abstract][Full Text] [Related]
16. Recombinant origin, contamination, and de-discovery of XMRV.
Delviks-Frankenberry K; Cingöz O; Coffin JM; Pathak VK
Curr Opin Virol; 2012 Aug; 2(4):499-507. PubMed ID: 22818188
[TBL] [Abstract][Full Text] [Related]
17. Androgen-independent proliferation of LNCaP prostate cancer cells infected by xenotropic murine leukemia virus-related virus.
Kakoki K; Kamiyama H; Izumida M; Yashima Y; Hayashi H; Yamamoto N; Matsuyama T; Igawa T; Sakai H; Kubo Y
Biochem Biophys Res Commun; 2014 Apr; 447(1):216-22. PubMed ID: 24721431
[TBL] [Abstract][Full Text] [Related]
18. An endogenous murine leukemia viral genome contaminant in a commercial RT-PCR kit is amplified using standard primers for XMRV.
Sato E; Furuta RA; Miyazawa T
Retrovirology; 2010 Dec; 7():110. PubMed ID: 21171978
[TBL] [Abstract][Full Text] [Related]
19. Lack of the detection of XMRV or polytropic MLV-related sequences in blood cells from HIV-1-infected patients in Spain.
Luczkowiak J; Martínez-Prats L; Sierra O; Fiorante S; Rubio R; Pulido F; Otero JR; Delgado R
J Acquir Immune Defic Syndr; 2012 Feb; 59(2):101-4. PubMed ID: 21963942
[TBL] [Abstract][Full Text] [Related]
20. Contamination of clinical specimens with MLV-encoding nucleic acids: implications for XMRV and other candidate human retroviruses.
Smith RA
Retrovirology; 2010 Dec; 7():112. PubMed ID: 21171980
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]